Back
NovoCure Vs. Surmodics Industry Stock Comparison
Buy
63
NVCR
NovoCure
Last Price:
22.19
Seasonality Move:
12.1%
Sell
43
SRDX
Surmodics
Last Price:
34.08
Seasonality Move:
10.22%
Buy
63
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $22.17. The Score for NVCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Surmodics (SRDX)
is a Sell
Is Surmodics a Buy, Sell or Hold?
- The current Surmodics [SRDX] share price is $34.08. The Score for SRDX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SRDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 86.3 | Buy |
| Chaikin Money Flow: | 1385306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.58 - 17.54) | Buy |
| Bollinger Bands (100): | (12.9 - 16.38) | Buy |
SRDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 68.4 | Buy |
| Chaikin Money Flow: | 22512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.07 - 32.75) | Buy |
| Bollinger Bands (100): | (27.93 - 34.29) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.21 | Buy |
| 20-day SMA: | 15.06 | Buy |
| 50-day SMA: | 14.55 | Buy |
| 200-day SMA: | 16.18 | Buy |
| 8-day EMA: | 18.77 | Buy |
| 20-day EMA: | 16.36 | Buy |
| 50-day EMA: | 15.09 | Buy |
| 200-day EMA: | 21.81 | Buy |
SRDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.63 | Buy |
| 20-day SMA: | 30.12 | Buy |
| 50-day SMA: | 28.81 | Buy |
| 200-day SMA: | 32.43 | Buy |
| 8-day EMA: | 32.72 | Buy |
| 20-day EMA: | 31.02 | Buy |
| 50-day EMA: | 30.06 | Buy |
| 200-day EMA: | 30.93 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.16 per share.
Surmodics Earnings Growth & SRDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.37 per share, and an increase next year of $0.30 per share.
NovoCure Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Surmodics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||